Back to Search Start Over

GDP- <scp>l</scp> -fucose synthase is a CD4 + T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis

Authors :
Mireia Sospedra
Roland Martin
Herena Eixarch
Carolina Cruciani
Raquel Planas
Andreas Lutterotti
Radleigh G. Santos
Clemencia Pinilla
Paula Tomas-Ojer
Wolfgang Faigle
Carmen Espejo
Nicole Schaeren-Wiemers
Source :
Science Translational Medicine. 10
Publication Year :
2018
Publisher :
American Association for the Advancement of Science (AAAS), 2018.

Abstract

Multiple sclerosis is an immune-mediated autoimmune disease of the central nervous system that develops in genetically susceptible individuals and likely requires environmental triggers. The autoantigens and molecular mimics triggering the autoimmune response in multiple sclerosis remain incompletely understood. By using a brain-infiltrating CD4 + T cell clone that is clonally expanded in multiple sclerosis brain lesions and a systematic approach for the identification of its target antigens, positional scanning peptide libraries in combination with biometrical analysis, we have identified guanosine diphosphate (GDP)–l-fucose synthase as an autoantigen that is recognized by cerebrospinal fluid–infiltrating CD4 + T cells from HLA-DRB3*–positive patients. Significant associations were found between reactivity to GDP-l-fucose synthase peptides and DRB3*02:02 expression, along with reactivity against an immunodominant myelin basic protein peptide. These results, coupled with the cross-recognition of homologous peptides from gut microbiota, suggest a possible role of this antigen as an inducer or driver of pathogenic autoimmune responses in multiple sclerosis.

Details

ISSN :
19466242 and 19466234
Volume :
10
Database :
OpenAIRE
Journal :
Science Translational Medicine
Accession number :
edsair.doi...........8272971b9dfed1cd9d35b632c489b01d